NYMX

Nymox Pharmaceutical Corp
NYMX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

37 hedge funds and large institutions have $444K invested in Nymox Pharmaceutical Corp in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

5% less capital invested

Capital invested by funds: $467K → $444K (-$23.5K)

Holders
37
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$16K
Puts
$2K
Net Calls
Net Calls Change

Top Buyers

1
+$27K
2
+$25K
3
+$16.2K
4
Jane Street
Jane Street
New York
+$8.12K
5
VF
Virtu Financial
New York
+$6K

Top Sellers

1
-$16K
2
-$13K
3
-$8K
4
GG
Gofen & Glossberg
Illinois
-$7K
5
Wells Fargo
Wells Fargo
California
-$3.69K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$3K
27
$2.97K
28
$2.23K
29
$2K
30
$1.52K
31
$1.47K
32
$1K
33
$389
34
$388
35
$120
36
$114
37
–
38
–
1
2